89 related articles for article (PubMed ID: 18513188)
1. Impact of neoadjuvant therapy on nodal harvest in clinical stage III rectal cancer: Establishing optimum cut-offs by disease response.
Wehrle CJ; Woo K; Chang J; Gamaleldin M; DeHaan R; Dahdaleh F; Felder S; Rosen DR; Champagne B; Steele SR; Naffouje SA
J Surg Oncol; 2024 Apr; 129(5):945-952. PubMed ID: 38221655
[TBL] [Abstract][Full Text] [Related]
2. Young Age Increases Risk of Lymph Node Positivity in Early-Stage Rectal Cancer.
Meyer JE; Cohen SJ; Ruth KJ; Sigurdson ER; Hall MJ
J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26719881
[TBL] [Abstract][Full Text] [Related]
3. Relevance of shrinkage versus fragmented response patterns in rectal cancer.
Kus Ozturk S; Graham Martinez C; Sheahan K; Winter DC; Aherne S; Ryan ÉJ; van de Velde CJ; Marijnen CA; Hospers GA; Roodvoets AG; Doukas M; Mens D; Verhoef C; van der Post RS; Nagtegaal ID
Histopathology; 2023 Dec; 83(6):870-879. PubMed ID: 37609761
[TBL] [Abstract][Full Text] [Related]
4. The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer.
Li Destri G; Maugeri A; Ramistella A; La Greca G; Conti P; Trombatore G; Vecchio GM; Magro GG; Barchitta M; Agodi A
Updates Surg; 2020 Sep; 72(3):793-800. PubMed ID: 32632764
[TBL] [Abstract][Full Text] [Related]
5. Associations of tumor regression grade with outcomes in patients with locally advanced rectal cancer treated with preoperative two-week course of radiotherapy.
Li YH; Li JL; Zhu XG; He JY; Lin LM; Lin XY; Tang LR; Cai Y
Oncotarget; 2017 Nov; 8(59):100165-100175. PubMed ID: 29245968
[TBL] [Abstract][Full Text] [Related]
6. Resected irradiated rectal cancers: Are twelve lymph nodes really necessary in the era of neoadjuvant therapy?
Cox ML; Adam MA; Shenoi MM; Turner MC; Sun Z; Mantyh CR; Migaly J
Am J Surg; 2018 Sep; 216(3):444-449. PubMed ID: 28890055
[TBL] [Abstract][Full Text] [Related]
7. Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?
Choi JP; Kim SJ; Park IJ; Hong SM; Lee JL; Yoon YS; Kim CW; Lim SB; Lee JB; Yu CS; Kim JC
Oncotarget; 2017 Feb; 8(6):10375-10384. PubMed ID: 28060748
[TBL] [Abstract][Full Text] [Related]
8. Understanding the factors associated with reduction in the number of lymph nodes in rectal cancer patients treated by neoadjuvant treatment.
Bustamante-Lopez L; Nahas CS; Nahas SC; Ribeiro U; Marques CF; Cotti G; Rocco A; Cecconello I
Int J Colorectal Dis; 2017 Jun; 32(6):925-927. PubMed ID: 28035459
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
[TBL] [Abstract][Full Text] [Related]
10. Response to chemoradiotherapy and lymph node involvement in locally advanced rectal cancer.
García-Flórez LJ; Gómez-Álvarez G; Frunza AM; Barneo-Serra L; Fresno-Forcelledo MF
World J Gastrointest Surg; 2015 Sep; 7(9):196-202. PubMed ID: 26425268
[TBL] [Abstract][Full Text] [Related]
11. A minimum yield of twelve lymph nodes in rectal cancer remains valid in the era of neo-adjuvant treatment : results from a national cohort study.
Lykke J; Jess P; Roikjaer O;
Int J Colorectal Dis; 2015 Mar; 30(3):347-51. PubMed ID: 25652878
[TBL] [Abstract][Full Text] [Related]
12. Relationships between SMAD3 expression and preoperative fluoropyrimidine-based chemoradiotherapy response in locally advanced rectal cancer patients.
Huang MY; Lin CH; Huang CM; Tsai HL; Huang CW; Yeh YS; Chai CY; Wang JY
World J Surg; 2015 May; 39(5):1257-67. PubMed ID: 25561186
[TBL] [Abstract][Full Text] [Related]
13. Commentary on neoadjuvant therapy followed by local excision and two-stage total mesorectal excision: a new strategy for sphincter preservation in locally advanced ultra-low rectal cancer.
Zbar AP
Gastroenterol Rep (Oxf); 2014 May; 2(2):134-5. PubMed ID: 24812283
[No Abstract] [Full Text] [Related]
14. DPYD, TYMS, TYMP, TK1, and TK2 genetic expressions as response markers in locally advanced rectal cancer patients treated with fluoropyrimidine-based chemoradiotherapy.
Huang MY; Wu CH; Huang CM; Chung FY; Huang CW; Tsai HL; Chen CF; Lin SR; Wang JY
Biomed Res Int; 2013; 2013():931028. PubMed ID: 24455740
[TBL] [Abstract][Full Text] [Related]
15. New ultrasound techniques for lymph node evaluation.
Cui XW; Jenssen C; Saftoiu A; Ignee A; Dietrich CF
World J Gastroenterol; 2013 Aug; 19(30):4850-60. PubMed ID: 23946589
[TBL] [Abstract][Full Text] [Related]
16. Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer.
Damin DC; Rosito MA; Contu PC; Tarta C; Ferreira PR; Kliemann LM; Schwartsmann G
J Gastrointest Surg; 2012 Aug; 16(8):1573-80. PubMed ID: 22618518
[TBL] [Abstract][Full Text] [Related]
17. The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer.
Berho M; Oviedo M; Stone E; Chen C; Nogueras J; Weiss E; Sands D; Wexner S
Colorectal Dis; 2009 Mar; 11(3):254-8. PubMed ID: 18513188
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
19. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
